Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer

Release Date:

Toni Choueiri describes the results of this renal cancer trial exploring rechallange with immune therapy

Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer

Title
Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer
Copyright
Release Date

flashback